Phase I/II trial of association of sorafenib in combination with temozolomide in patients with metastatic melanoma: Looking for predictive markers of efficacy

被引：0
|
作者：
Robert, C.
Chaput, N.
Lassau, N.
Auperin, A.
Koscielny, S.
Hollville, E.
Lazar, V.
Lacroix, L.
Soria, J.
Mateus, C.
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Inst Gustave Roussy, Dept Biopathol, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.8552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8552
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512
    Bhatia, Shailender
    Moon, James
    Margolin, Kim A.
    Weber, Jeffrey S.
    Lao, Christopher D.
    Othus, Megan
    Aparicio, Ana M.
    Ribas, Antoni
    Sondak, Vernon K.
    PLOS ONE, 2012, 7 (11):
  • [22] Phase I trial of temozolomide, thalidimide, and lomustine in patients with metastatic melanoma in the brain.
    Papadopoulos, N. E.
    Hwu, W.
    Cain, S.
    Posada, L.
    Kim, K. B.
    Homsi, J.
    Bedikian, A. Y.
    Davies, M. A.
    Hwu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [23] Phase II trial of carboplatin, paclitaxel and temozolomide in metastatic melanoma.
    Araujo-Mino, Emilio Paul
    Shaheen, Montaser F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma
    Pettijohn, Erin
    Martone, Brenda
    Rademaker, Alfred
    Kuzel, Timothy
    JOURNAL OF PERSONALIZED MEDICINE, 2014, 4 (04) : 448 - 458
  • [25] A Phase I study of temozolomide and carboplatin in patients with metastatic melanoma
    Strauss, SJ
    Marples, M
    Meyer, T
    Napier, M
    Boxall, J
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2001, 85 : 51 - 51
  • [26] A phase I/II gene therapy trial in metastatic melanoma patients
    Adamina, Michel
    Weber, Walter P.
    Rosenthal, Rachel
    Schumacher, Reto
    Zajac, Paul
    Marti, Walter R.
    Huegli, Rolf
    Oertli, Daniel
    Spagnoli, Giulio
    Heberer, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (03) : S83 - S83
  • [27] A phase I/II study to determine the feasibility and efficacy of the triple combination of Oblimersen (OBL), Abraxane (ABX), and Temozolomide (TMZ) in metastatic melanoma
    Pavlick, A.
    Volm, M.
    Ryan, T.
    Escalon, J.
    Lee, L.
    Liebes, L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 395 - 395
  • [28] Phase I trial of sorafenib in combination with IFN α-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma
    Escudier, Bernard
    Lassau, Nathalie
    Angevin, Eric
    Soria, Jean Charles
    Chami, Linda
    Lamuraglia, Michele
    Zafarana, Eric
    Landreau, Veronique
    Schwartz, Brian
    Brendel, Eric
    Armand, Jean-Pierre
    Robert, Caroline
    CLINICAL CANCER RESEARCH, 2007, 13 (06) : 1801 - 1809
  • [29] Phase II trial of neoadjuvant temozolomide in resectable melanoma patients
    Shah, G. D.
    Socci, N. D.
    Gold, J. S.
    Wolchok, J. D.
    Carvajal, R. D.
    Panageas, K. S.
    Viale, A.
    Brady, M. S.
    Coit, D. G.
    Chapman, P. B.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1718 - 1722
  • [30] A MULTICENTRE, PHASE II STUDY OF CP-4055 IN COMBINATION WITH SORAFENIB IN PATIENTS WITH METASTATIC MALIGNANT MELANOMA
    Dueland, S.
    Aamdal, S.
    Nyakas, M.
    Lundgren, L.
    Wagenius, G.
    Ljuslinder, I.
    Stierner, U.
    Gaullier, J.
    Nilsson, B. I.
    Rasch, W.
    ANNALS OF ONCOLOGY, 2008, 19 : 245 - 246
12345